Suppr超能文献

相似文献

1
PSGL-1: A New Player in the Immune Checkpoint Landscape.
Trends Immunol. 2017 May;38(5):323-335. doi: 10.1016/j.it.2017.02.002. Epub 2017 Mar 2.
2
PSGL-1 function in immunity and steady state homeostasis.
Immunol Rev. 2009 Jul;230(1):75-96. doi: 10.1111/j.1600-065X.2009.00797.x.
3
P-selectin glycoprotein ligand-1 negatively regulates T-cell immune responses.
J Immunol. 2009 Dec 1;183(11):7204-11. doi: 10.4049/jimmunol.0902173. Epub 2009 Nov 4.
4
PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE.
Eur J Immunol. 2014 Aug;44(8):2287-94. doi: 10.1002/eji.201344214. Epub 2014 May 11.
5
P-selectin glycoprotein ligand-1 in T cells.
Curr Opin Hematol. 2017 May;24(3):265-273. doi: 10.1097/MOH.0000000000000331.
7
p85-RhoGDI2, a novel complex, is required for PSGL-1-induced β1 integrin-mediated lymphocyte adhesion to VCAM-1.
Int J Biochem Cell Biol. 2013 Dec;45(12):2764-73. doi: 10.1016/j.biocel.2013.09.005. Epub 2013 Sep 17.
8
Homing in on the Sweet Side of Immune Checkpoint Biology.
Immunity. 2016 May 17;44(5):1083-5. doi: 10.1016/j.immuni.2016.05.003.
10
PSGL-1: a novel immune checkpoint driving T-cell dysfunction in obstructive sleep apnea.
Front Immunol. 2023 Oct 3;14:1277551. doi: 10.3389/fimmu.2023.1277551. eCollection 2023.

引用本文的文献

1
The Role of Glycans in Human Immunity-A Sweet Code.
Molecules. 2025 Jun 20;30(13):2678. doi: 10.3390/molecules30132678.
2
Insights into Pulmonary Arterial Hypertension in Connective Tissue Diseases.
J Clin Med. 2025 Jul 4;14(13):4742. doi: 10.3390/jcm14134742.
4
Negative Immune Checkpoint Inhibitors.
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
5
6
Exploring New Frontiers: Alternative Breast Cancer Treatments Through Glycocalyx Research.
Breast J. 2025 May 22;2025:9952727. doi: 10.1155/tbj/9952727. eCollection 2025.
7
Type 2 diabetes abates retrograde collateral flow and promotes leukocyte adhesion following ischemic stroke.
J Cereb Blood Flow Metab. 2025 May 29:271678X251338203. doi: 10.1177/0271678X251338203.
8
Immune inhibitory receptor agonist therapeutics.
Front Immunol. 2025 Mar 26;16:1566869. doi: 10.3389/fimmu.2025.1566869. eCollection 2025.

本文引用的文献

1
Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity.
Sci Rep. 2016 Nov 28;6:37953. doi: 10.1038/srep37953.
2
The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations.
Pigment Cell Melanoma Res. 2016 Sep;29(5):590-7. doi: 10.1111/pcmr.12498. Epub 2016 Aug 3.
3
PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.
Immunity. 2016 May 17;44(5):1190-203. doi: 10.1016/j.immuni.2016.04.015.
4
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.
Immunity. 2016 May 17;44(5):1052-68. doi: 10.1016/j.immuni.2016.04.022.
5
Platelets Guide Leukocytes to Their Sites of Extravasation.
PLoS Biol. 2016 May 6;14(5):e1002459. doi: 10.1371/journal.pbio.1002459. eCollection 2016 May.
6
PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease.
PLoS Pathog. 2016 Mar 14;12(3):e1005500. doi: 10.1371/journal.ppat.1005500. eCollection 2016 Mar.
7
O-glycans direct selectin ligands to lipid rafts on leukocytes.
Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8661-6. doi: 10.1073/pnas.1507712112. Epub 2015 Jun 29.
8
Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites.
Biochemistry. 2015 Jul 14;54(27):4163-6. doi: 10.1021/acs.biochem.5b00560. Epub 2015 Jul 6.
9
The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.
Immunity. 2015 Feb 17;42(2):265-278. doi: 10.1016/j.immuni.2015.01.006. Epub 2015 Feb 10.
10
Leukocyte migration into inflamed tissues.
Immunity. 2014 Nov 20;41(5):694-707. doi: 10.1016/j.immuni.2014.10.008.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验